affordable compounded semaglutide Safest and Cheapest Compounding Pharmacy for Cheapest Semaglutide and Tirzepatide Plans

Metabolic Health Encourages balanced insulin response and steady energy throughout the day

Reviewed July 8, 2026.

A significant wave of patent and data protection expires in 2026 across eight key markets in wave 1: Canada, Brazil, China, India, Mexico , Turkey, Saudi Arabia* and South Africa (see Figure 1)

Retatrutide is a next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously, making it the most advanced

Hanmi expects to initiate Phase 1 clinical trials for HM17321 in the second half of 2025.According to recent reports from GlobalData Patent Analytics and IFI CLAIMS Patent Services, Hanmi ranks among the global leaders in both the volume and quality of obesity drug patent filings, alongside multinational pharmaceutical companies such as Eli Lilly and Novo Nordisk.Innovation in metabolic and endocrine diseases has been a core focus for Hanmi over many years, and the ADA 2025 presentations represent a critical opportunity to showcase our global competitiveness, said Dr